DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

Molecular and Cellular Biology

Volumn 19, Issue 11, 1999, Pages 7327-7335

  De Smet, Charles ^a   Lurquin, Christophe ^a   Lethé, Bernard ^a   Martelange, Valérie ^a   Boon, Thierry ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE; TRANSCRIPTION FACTOR; TUMOR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA FLANKING REGION; DNA METHYLATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

EID: 0032694084     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.11.7327     Document Type: Article

References (53)

1. Antequera, F., and A. Bird. 1993. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90:11995-11999.
2. Antequera, F., J. Boyes, and A. Bird. 1990. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62:503-514.
3. Baylin, S. B., J. G. Herman, J. R. Graff, P. M. Vertino, and J.-P. Issa. 1998. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:141-196.
4. Bird, A. 1992. The essentials of DNA methylation. Cell 70:5-8.
5. Bird, A. P. 1995. Gene number, noise reduction and biological complexity. Trends Genet. 11:94-100.
6. Bonny, C., and E. Goldberg. 1995. The CpG-rich promoter of human LDH-C is differentially methylated in expressing and nonexpressing tissues. Dev. Genet. 16:210-217.
7. Chen, Y., M. Scanlan, U. Sahin, Ö. Türeci, A. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94:1914-1918.
8. Choi, Y.-C., and C.-B. Chae. 1991. DNA hypomethylation and germ cell-specific expression of testis-specific H2B histone gene. J. Biol. Chem. 266: 20504-20511.
9. Cross, S. H., and A. P. Bird. 1995. CpG islands and genes. Curr. Opin. Genet. Dev. 5:309-314.
10. De Backer, O., K. C. Arden, M. Boretti, V. Vantomme, C. De Smet, S. Czekay, C. S. Viars, E. De Plaen, F. Brasseur, P. Chomez, B. Van den Eynde, T. Boon, and P. van der Bruggen. 1999. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res. 59:3157-3165.
11. De Plaen, E., K. Arden, C. Traversai, J. J. Gaforio, J.-P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethé, C. Lurquin, R. Brasseur, P. Chomez, O. De Backer, W. Cavenee, and T. Boon. 1994. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 40:360-369.
12. - mutation. Proc. Natl. Acad. Sci. USA 85:2274-2278.
13. De Smet, C., S. J. Courtois, I. Faraoni, C. Lurquin, J.-P. Szikora, O. De Backer, and T. Boon. 1995. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 42:282-290.
14. De Smet, C., O. De Backer, I. Faraoni, C. Lurquin, F. Brasseur, and T. Boon. 1996. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 93:7149-7153.
15. De Smet, C., C. Lurquin, P. van der Bruggen, E. De Plaen, F. Brasseur, and T. Boon. 1994. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39:121-129.
16. De Smet, C., V. Martelange, S. Lucas, F. Brasseur, C. Lurquin, and T. Boon. 1997. Identification of testis-specific transcripts and analysis of their expression in tumor cells. Biochem. Biophys. Res. Commun. 241:653-657.
17. del Mazo, J., G. Prantera, T. Miguel, and M. Ferraro. 1994. DNA methylation changes during mouse spermatogenesis. Chromosome Res. 2:147-152.
18. Diala, E. S., M. S. C. Cheah, D. Rotwich, and R. M. Hoffman. 1983. Extent of methylation in human tumor cells. J. Natl. Cancer Inst. 71:755-764.
19. Driscoll, D. J., and B. R. Migeon. 1990. Sex differences in methylation of single-copy genes in human meiotic germ cells: implication for X chromosome inactivation, parental imprinting, and origin of CpG mutations. Somatic Cell Mol. Genet. 16:267-282.
20. Eden, S., and H. Cedar. 1994. Role of DNA methylation in the regulation of transcription. Curr. Opin. Genet. Dev. 4:255-259.
21. Frommer, M., L. E. MacDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul, 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89:1827-1831.
22. Gama-Sosa, M. A., V. A. Slagel, R. W. Trewyn, R. Oxenhandler, K. C. Kuo, C. W. Gehrke, and M. Ehrlich. 1983. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11:6883-6894.
23. Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-282.
24. Hellmann-Blumberg, U., M. F. Hintz, J. M. Gatewood, and C. W. Schmid. 1993. Developmental differences in methylation of human A1u repeats. Mol. Cell. Biol. 13:4523-4530.
25. Jones, P. A., S. M. Taylor, T. Mohandas, and L. J. Shapiro. 1982. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc. Natl. Acad. Sci. USA 79:1215-1219.
26. Jones, P. A., M. J. Wolkowicz, M. A. Harrington, and F. Gonzales. 1990. Methylation and expression of the Myo D1 determination gene. Philos. Trans. R. Soc. Lond. Ser. B 326:277-284.
27. Kass, S. U., N. Landsberger, and A. P. Wolffe. 1997. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7:157-65.
28. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman. 1996. A role for nuclear NF-kB in B-cell-specific demethylation of the lgk locus. Nat. Genet. 13:435-441.
29. Larsen, F., G. Gundersen, R. Lopez, and H. Prydz. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095-107.
30. Lethé, B., S. Lucas, L. Michaux, C. De Smet, D. Godelaine, A. Serrano, E. De Plaen, and T. Boon. 1998. LAGE-1, a new gene with tumor specificity. Int. J. Cancer 76:903-908.
31. Lethé, B., P. van der Bruggen, F. Brasseur, and T. Boon. 1997. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte. Melanoma Res. 7(Suppl. 2):S83-S88.
32. Li, E., C. Beard, and R. Jaenisch. 1993. Role for DNA methylation in genomic imprinting. Nature 25:362-365.
33. Li, E., T. H. Bester, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
34. Lucas, S., C. De Smet, K. C. Arden, C. S. Viars, B. Lethé, C. Lurquin, and T. Boon. 1998. Identification of a new MAGE gene with tumor-specific expression hy representational difference analysis. Cancer Res. 58:743-752.
35. Lurquin, C., C. De Smet, F. Brasseur, F. Muscatelli, V. Martelange, E. De Plaen, R. Brasseur, A. P. Monaco, and T. Boon. 1997. Two members of the human MAGE-B gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46:397-408.
36. McCarrey, J. R., W. M. Berg, S. J. Paragioudakis, P. L. Zhang, D. D. Dilworth, B. L. Arnold, and J. J. Rossi. 1992. Differential transcription of Pgk genes during spermatogenesis in the mouse. Dev. Biol. 154:160-168.
37. Muscatelli, F., A. P. Walker, E. De Plaen, A. N. Stafford, and A. P. Monaco. 1995. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA 92:4987-4991.
38. Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
39. Park, J. G., and V. M. Chapman. 1994. CpG island promoter region methylation patterns of the inactive-X-chromosome hypoxanthine phosphoribosyltransferase (Hprt) gene. Mol. Cell. Biol. 14:7975-7883.
40. Pfeifer, G. P., S. D. Steigerwald, R. S. Hansen, S. M. Gartler, and A. D. Riggs. 1990. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc. Natl. Acad. Sci. USA 87:8252-8256.
41. Riggs, A. D., and P. A. Jones. 1983. 5-methylcytosine, gene regulation, and cancer. Adv. Cancer Res. 40:1-30.
42. Riggs, A. D., and G. P. Pfeifer. 1992. X-chromosome inactivation and cell memory. Trends Genet. 8:169.
43. Rocamora, N., and C. Mezquita. 1989. Chicken spermatogenesis is accompanied by a genome-wide loss of DNA methylation. FEBS Lett. 247:415-418.
44. Stein, R., A. Razin, and H. Cedar. 1982. In vitro methylation of the hamster adenine phosphoribosyltransferase gene inhibits its expression in mouse L. cells. Proc. Natl. Acad. Sci. USA 79:3418-3422.
45. Stögert, R., P. Kubicka, C.-G. Liu, T. Kafri, A. Razin, H. Cedar, and D. P. Barlow. 1993. Maternal specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73:61-71.
46. Takahashi, K., S. Shiehijo, M. Noguchi, M. Hirohata, and K. Itoh. 1995. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55:3478-3482.
47. Traversari, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transaction and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35:145-152.
48. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
49. Van den Eynde, B., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684-693.
50. Walsh, C. P., and T. H. Bestor. 1999. Cytosine methylation and mammalian development. Genes Dev. 13:26-34.
51. Weber, J., M. Salgaller, D. Samid, B. Johnson, M. Herłyn, N. Lassam, J. Treisman, and S. A. Rosenberg. 1994. Expression of the MAGE1 tumor antigen is upregulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res. 54:1766-1771.
52. Weih, F., D. Nitsch, G. Schütz, and P. B. Becker. 1991. Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J. 10:2556-2567.
53. Woodcock, D. M., C. B. Lawler, M. E. Linsenmeyer, J. P. Doherty, and W. D. Warren. 1997. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J. Biol. Chem. 272:7810-7816.